Prophylaxis of Venous Thromboembolism After Bariatric Surgery
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study is a prospective evaluation of the relationship between lean body weight and
anti-Xa activity and 5700 International Units (IU) nadroparin 4 hours after subcutaneous
administration in morbidly obese patients after bariatric surgery.